Nevada 2017 Regular Session Status: Enacted 1 D cosponsors

AB 214 — Establishes a program to increase participation by certain demographic groups in clinical trials. (BDR 40-707)

Last action — Approved by the Governor. Chapter 142.

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed Assembly
  4. ✓
    Passed Senate
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced February 13, 2017. Enacted.

Prognosis

Advancing 52% · moderate confidence

Where this bill stands today.

Odds of enactment

High

How often bills like it became law.

  • Enacted

    Current position in the legislative process.

  • 1 sponsor

    1 primary, 0 co-sponsors signed on.

  • Single-party support

    Sponsorship is currently within one party (1 D).

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Bill Text

What changed in the latest version

93 added · 105 removed

93 line(s) added, 105 removed.

→
Previous
Latest
(Reprinted with amendments adopted on May 16, 2017) SECOND REPRINT A.B.
Assembly Bill No.
214 A SSEMBLY BILL NO .
214–Assemblywoman Neal CHAPTER..........
214–ASSEMBLYWOMAN NEAL PREFILED F EBRUARY 13, 2017 ____________ Referred to Committee on Health and Human Services SUMMARY—Establishes a program to increase participation by certain demographic groups in clinical trials.
(BDR 40-707) FISCAL NOTE:
EfEffect on the State:
Yes.
May have Fiscal Impact.
~ EXPLANATION – Matter in bolded italics is new;
matter between brackets [omitted material] is material to be omitted.
Department of Health and Human Services to establish various programs relating to the provision of health care and the improvement of public health in this State.
Existing law requires the Division of Public and Behavioral Health of the the provision of health care and the improvement of public health in this State.o (NRS 439.495, 439.501, 439.517, 439.5295) This bill requires the Division to establish a program to encourage participation in clinical trials of drugs and medical devices by persons who are members of demographic groups that are underrepresented in such trials.
(NRS 439.495, 439.501, 439.517, 439.5295) This bill requires the Division to establish a program to encourage participation in clinical trials of drugs and medical devices by persons who are members of demographic groups that are governmental entity that conducts such trials to adopt a policy concerning the identification and recruitment of such persons to participate in those trials.
This bill also requires each state or local identification and recruitment of such persons to participate in those trials.
EXPLANATION – Matter in bolded italics is new;
matter between brackets [omitted material] is material to be omitted.
- *AB214_R2* – 2 – (a) Improve the completeness and quality of data concerning diverse demographic groups that is collected, reported and analyzed for the purposes of clinical trials of drugs and medical devices;
(a) Improve the completeness and quality of data concerning diverse demographic groups that is collected, reported and analyzed for the purposes of clinical trials of drugs and medical devices;
(a) The Division shall review the most recent version of “Collection of Race and Ethnicity Data in Clinical Trials— Guidance for Industry and Food and Drug Administration Staff,” published by the United States Food and Drug Administration, and establish, using existing infrastructure and tools, a program to encourage participation in clinical trials of drugs and medical devices by persons who are members of demographic groups that are underrepresented in such clinical trials.
- 79th Session (2017) – 2 – (a) The Division shall review the most recent version of “Collection of Race and Ethnicity Data in Clinical Trials— Guidance for Industry and Food and Drug Administration Staff,” published by the United States Food and Drug Administration, to encourage participation in clinical trials of drugs and medical devices by persons who are members of demographic groups that are underrepresented in such clinical trials.
(b) With the assistance of the Office of Grant Procurement, Coordination and Management of the Department of Administration, the Division shall apply for grants from any - *AB214_R2* – 3 – source, including, without limitation, the Federal Government, to fund the program established pursuant to paragraph (a).
Coordinationthe andistaManagement Offiof oftheantDepartmentnt, of Administration, the Division shall apply for grants from any source, including, without limitation, the Federal Government, to fund the program established pursuant to paragraph (a).
(d) Each state or local governmental entity that conducts clinical trials of drugs or medical devices, including, without limitation, the Board of Regents of the University of Nevada, shall adopt a policy concerning the identification and recruitment of persons who are members of underrepresented demographic groups to participate in those clinical trials.
(d) Each state or local governmental entity that conducts clinical trials of drugs or medical devices, including, without limitation, the Board of Regents of the University of Nevada, shall adopt a policy concerning the identification and recruitment of persons who are members of underrepresented demographic - 79th Session (2017) – 3 – groups to participate in those clinical trials.
Such a policy must include, without limitation, requirements that investigators who are conducting clinical trials collaborate with community-based organizations and use methods recognized by the United States Food and Drug Administration to identify and recruit such persons to participate in those clinical trials.
Such a policy must include, without limitation, requirements that investigators who are conducting clinical trials collaborate with community-based organizations and use methods recognized by the United States persons to participate in those clinical trials.ruit such 3.
3.
not apply to any provision of this act which adds or revises ao requirement to submit a report to the Legislature.
1.5.
The provisions of subsection 1 of NRS 218D.380 do not apply to any provision of this act which adds or revises a requirement to submit a report to the Legislature.
Sec.
H - *AB214_R2*
~~~~~ 17 - 79th Session (2017)
⬇ Download PDF
View plain text versions (4)

Action History

  1. Approved by the Governor. Chapter 142.

  2. Enrolled and delivered to Governor.

  3. Senate Amendment No. 671 concurred in. To enrollment.

  4. In Assembly.

  5. Read third time. Passed, as amended. Title approved. (Yeas: 21, Nays: None.) To Assembly.

  6. From printer. To re-engrossment. Re-engrossed. Second reprint .

  7. Read second time. Amended. (Amend. No. 671.) To printer.

  8. Placed on Second Reading File.

  9. From committee: Amend, and do pass as amended.

  10. Read first time. Referred to Committee on Health and Human Services. To committee.

  11. In Senate.

  12. Read third time. Passed, as amended. Title approved. (Yeas: 42, Nays: None.) To Senate.

  13. From printer. To engrossment. Engrossed. First reprint .

  14. Read second time. Amended. (Amend. No. 41.) To printer.

  15. Placed on Second Reading File for next legislative day.

  16. Taken from Second Reading File.

  17. Notice of eligibility for exemption.

  18. From committee: Amend, and do pass as amended.

  19. From printer. To committee.

  20. Read first time. Referred to Committee on Health and Human Services. To printer.

  21. Prefiled pursuant to JSR 14.2.1(d).

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 66 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (66)

66 members have not signed on to this bill.

Show all 66 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

civil-rights healthcare education
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors AB 214?
AB 214 is sponsored by Neal, Dina (Democratic).
What is the current status of AB 214?
This bill has been enacted into law. Introduced February 13, 2017. Enacted.
Where can I track AB 214?
Track AB 214 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on AB 214

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of AB 214

Last checked for changes 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →